WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Renovaro Biosciences Inc. (NASDAQ: RENB) resulting from allegations that Renovaro may have issued materially misleading business information to the investing public. Read More